These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30390395)

  • 1. Open-label trial of ranolazine for the treatment of paramyotonia congenita.
    Lorusso S; Kline D; Bartlett A; Freimer M; Agriesti J; Hawash AA; Rich MM; Kissel JT; David Arnold W
    Muscle Nerve; 2019 Feb; 59(2):240-243. PubMed ID: 30390395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label trial of ranolazine for the treatment of myotonia congenita.
    Arnold WD; Kline D; Sanderson A; Hawash AA; Bartlett A; Novak KR; Rich MM; Kissel JT
    Neurology; 2017 Aug; 89(7):710-713. PubMed ID: 28710329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on clinical presentation and management of nondystrophic myotonias.
    Stunnenberg BC; LoRusso S; Arnold WD; Barohn RJ; Cannon SC; Fontaine B; Griggs RC; Hanna MG; Matthews E; Meola G; Sansone VA; Trivedi JR; van Engelen BGM; Vicart S; Statland JM
    Muscle Nerve; 2020 Oct; 62(4):430-444. PubMed ID: 32270509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine may be effective for treatment of paramyotonia congenita.
    Ravaglia S; Maggi L; Zito A; Arceri S; Gallotti P; Altamura C; Desaphy JF; Bernasconi P; Alfonsi E
    Muscle Nerve; 2021 Jul; 64(1):95-99. PubMed ID: 33835497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium channel slow inactivation as a therapeutic target for myotonia congenita.
    Novak KR; Norman J; Mitchell JR; Pinter MJ; Rich MM
    Ann Neurol; 2015 Feb; 77(2):320-32. PubMed ID: 25515836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study.
    Khadilkar SV; Singh RK; Mansukhani KA; Urtizberea JA; Sternberg D
    Muscle Nerve; 2010 Jan; 41(1):133-7. PubMed ID: 19768756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eulenburg's paramyotonia congenita].
    Sallansonnet-Froment M; Bounolleau P; De Greslan T; Ricard D; Taillia H; Renard JL
    Rev Neurol (Paris); 2007 Nov; 163(11):1083-90. PubMed ID: 18033047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.
    El-Bizri N; Kahlig KM; Shyrock JC; George AL; Belardinelli L; Rajamani S
    Channels (Austin); 2011; 5(2):161-72. PubMed ID: 21317558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.
    Stunnenberg BC; Raaphorst J; Groenewoud HM; Statland JM; Griggs RC; Woertman W; Stegeman DF; Timmermans J; Trivedi J; Matthews E; Saris CGJ; Schouwenberg BJ; Drost G; van Engelen BGM; van der Wilt GJ
    JAMA; 2018 Dec; 320(22):2344-2353. PubMed ID: 30535218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
    Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
    J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
    Andersen G; Hedermann G; Witting N; Duno M; Andersen H; Vissing J
    Brain; 2017 Sep; 140(9):2295-2305. PubMed ID: 29050397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Vicart S; Franques J; Bouhour F; Magot A; Péréon Y; Sacconi S; Nadaj-Pakleza A; Behin A; Zahr N; Hézode M; Fournier E; Payan C; Lacomblez L; Fontaine B
    Neuromuscul Disord; 2021 Nov; 31(11):1124-1135. PubMed ID: 34702654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita.
    van Osch T; Stunnenberg BC; Sternberg D; Kerklaan BJ
    Muscle Nerve; 2018 Oct; 58(4):E27-E28. PubMed ID: 30028520
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful long-term therapy with flecainide in a family with paramyotonia congenita.
    Terracciano C; Farina O; Esposito T; Lombardi L; Napolitano F; Blasiis P; Ciccone G; Todisco V; Tuccillo F; Bernardini S; Di Iorio G; Melone MAB; Sampaolo S
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1232-1234. PubMed ID: 29487168
    [No Abstract]   [Full Text] [Related]  

  • 15. Paramyotonia congenita due to a de novo mutation: a case report.
    Fukudome T; Izumoto H; Goto H; Matsuo H; Yoshimura T; Sakoda S; Shibuya N
    Muscle Nerve; 2003 Aug; 28(2):232-5. PubMed ID: 12872329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy.
    Mankodi A; Grunseich C; Skov M; Cook L; Aue G; Purev E; Bakar D; Lehky T; Jurkat-Rott K; Pedersen TH; Childs RW
    Neuromuscul Disord; 2015 Nov; 25(11):908-12. PubMed ID: 26494408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromyographic distinction between paramyotonia congenita and myotonia congenita: effect of cold.
    Nielsen VK; Friis ML; Johnsen T
    Neurology; 1982 Aug; 32(8):827-32. PubMed ID: 7201578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo assessment of muscle membrane properties in the sodium channel myotonias.
    Tan SV; Z'Graggen WJ; Hanna MG; Bostock H
    Muscle Nerve; 2018 Apr; 57(4):586-594. PubMed ID: 28877545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramyotonia Congenita with Persistent Distal and Facial Muscle Weakness: A Case Report with Literature Review.
    Taminato T; Mori-Yoshimura M; Miki J; Sasaki R; Sato N; Oya Y; Nishino I; Takahashi Y
    J Neuromuscul Dis; 2020; 7(2):193-201. PubMed ID: 32083589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.